- Home
- MRK vs MRVL Comparison
MRK vs MRVL Comparison
Compare MRK & MRVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | MRVL |
|---|---|---|
| Founded | 2000 | 1995 |
| Country | United States | United States |
| Employees | N/A | 7480 |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.2B | 242.1B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MRK | MRVL |
|---|---|---|
| Price | $127.19 | $266.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 32 |
| Target Price | ★ $125.59 | $120.28 |
| AVG Volume (30 Days) | 8.6M | ★ 59.5M |
| Earning Date | 04-30-2026 | 05-28-2026 |
| Dividend Yield | ★ 3.06% | 0.15% |
| EPS Growth | 8.01 | ★ 400.98 |
| EPS | N/A | ★ 0.04 |
| Revenue | ★ $65,011,000,000.00 | $8,194,600,000.00 |
| Revenue This Year | $3.61 | $35.14 |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | ★ N/A | $7,021.25 |
| Revenue Growth | 1.31 | ★ 42.09 |
| 52 Week Low | $76.66 | $61.44 |
| 52 Week High | $125.96 | $329.88 |
Technical Indicators
Market Signals| Indicator | MRK | MRVL |
|---|---|---|
| Relative Strength Index (RSI) | 70.38 | 52.21 |
| Support Level | $112.68 | $78.57 |
| Resistance Level | N/A | $327.04 |
| Average True Range (ATR) | 3.07 | 24.89 |
| MACD | 0.91 | -6.01 |
| Stochastic Oscillator | 97.44 | 24.95 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About MRVL Marvell Technology Inc.
Marvell Technology is a fabless chip designer focused on wired networking, where it has the second-highest market share. Marvell serves the data center, carrier, enterprise, and consumer end markets with processors, optical and copper transceivers, switches, and storage controllers.